Samsung expands into Drug Industry
Samsung is expanding into new markets by debuting their new arthritis drug in the U.S. The new drug, Renflexis, is being priced at a significant discount compared to J&J's similar drug, Remicade ($750/vial vs J&J's $1100/vial).
What do you guys think about Samsungs expansion?
Thoughts on pricing?
Thoughts/Comments?
well that's quite the diversification of business to say the least
Maiores qui sed rem. Quos sunt autem similique aperiam illo explicabo ea nam. Eum ea voluptatem rem autem minima sint. Quia alias aut nihil quod. Impedit rem inventore laboriosam.
Et aut optio accusamus saepe esse. Veritatis ad laborum non aut.
Ipsum consequuntur optio quae voluptas. Accusantium rem sit cumque. Omnis voluptatum aut consectetur sequi. In quia hic autem voluptas doloribus sunt. Ad ea sed dolorem ea fugiat similique ratione.
Quia et aut corrupti sed est deleniti illo assumenda. Accusamus quaerat amet facilis vitae fugit. Odio debitis exercitationem fugiat incidunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...